nectin-4

Sarah Cronjaeger1, Lena Seifert2, Adrian M Seifert3

  • 1Department of Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; National Center for Tumor Diseases (NCT), Dresden, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.

Trends in cancer
|March 11, 2026
PubMed
概括

尼克-4促进胰腺癌的攻击性和免疫逃避. 用抗体-药物合物向nectin-4是一种有前途的治疗策略,用于胰腺管道腺癌 (PDAC).